| Literature DB >> 26413367 |
Diaa Al Safatli1, Rolf Kalff1, Albrecht Waschke1.
Abstract
Rathke cleft cyst is described as benign intrasellar cyst. They are mostly small and asymptomatic; they may become large enough to cause symptoms by compression of intrasellar or suprasellar structures. We report on a case of spontaneous regression of a symptomatic RCC with subsequent recovery of preexisting endocrine dysfunction and resolution of headaches. A 60-year-old man complained about headaches. Laboratory investigation revealed a partial hypopituitarism with a slight central hypothyroidism without need for substitution. An MRI study showed a cystic, T2-hyperintense, sellar lesion compatible with a RCC. At one year follow-up, the patient had no complaints and the hormone work-up revealed a regression of the previous slight hypopituitarism. The MRI study showed a complete regression of the cystic lesion and a normal sized and shaped pituitary gland. The spontaneous regression of cystic sellar lesions is rare. The exact mechanism of the possible spontaneous involution of RCC is until now not well understood. However, spontaneous regression is possible and justifies the conservative therapy with regular clinical and radiological follow-up for asymptomatic patients or patients with symptoms not caused by the mass effect of these lesions.Entities:
Year: 2015 PMID: 26413367 PMCID: PMC4564632 DOI: 10.1155/2015/971364
Source DB: PubMed Journal: Case Rep Surg
Figure 1(a–c) The MRI images by the initial diagnosis, (a) T1-coronal without contrast, (b) T1-coronal with contrast, and (c) T2-axial without contrast. (d–f) The MRI images by the 1-year follow-up, (d) T1-coronal without contrast, (e) T1-coronal with contrast, and (f) T2-coronal without contrast.
Reported cases of spontaneous regression of RCC.
| Case number | Authors and year | Age (yrs), sex | Symptoms | Time to regression (mos) | Endocrine evaluation |
|---|---|---|---|---|---|
| 1 |
J. D. Simmons and L. A. Simmons, 1999 [ | 15, F | Amenorrhea | 3 | Low LH, FSH, and estradiol |
|
| |||||
| 2 |
Igarashi et al., 1999 [ | 25, F | Visual field defect | NA | NA |
| 46, M | Visual field defect | NA | NA | ||
| 34, M | Visual field defect | NA | NA | ||
| 58, F | Visual field defect | NA | NA | ||
|
| |||||
| 3 | Saeki et al., 1999 [ | 59, F | Visual field defect | 1 | Normal |
| 30, M | Visual field defect | 0.5 | Low LH, FSH, and GH | ||
|
| |||||
| 4 | Terao et al., 2001 [ | 67, M | Visual field defect | 60 | NA |
|
| |||||
| 5 |
Nishio et al., 2001 [ | 14, M | Headache | 3 | Normal |
| 31, F | Headache | 6 | Normal | ||
|
| |||||
| 6 |
Nishioka et al., 2006 [ | NA | NA | NA | Hypopituitarism |
| NA | Visual field defect | NA | NA | ||
|
| |||||
| 7 | Maruyama et al., 2008 [ | 81, M | Headache | 0.5 | Hypopituitarism |
|
| |||||
| 8 |
Amhaz et al., 2010 [ | 57, M | Headache | 5 | Low testosterone |
| 32, F | Headache | 44 | Normal | ||
| 29, F | None | 31 | Normal | ||
| 18, F | Headache | 7 | Elevated ACTH | ||
| 17, F | Headache | 21 | Normal | ||
| 14, M | Headache | 11 | GH slightly high | ||
| 6, M | Headache | 41 | Normal | ||
| 5, M | Growth | 100 | Low testosterone and TSH | ||
| 29, F | deceleration | 18 | Normal | ||
|
| |||||
| 9 | Maniec and Watson, 2011 [ | 59, M | Headache | 6 | NA |
|
| |||||
| 10 | Munich and Leonardo, 2012 [ | 8.5, F | Growth deceleration | 12 | Low GH, central hypothyroidism |
NA, information not available in paper; M, male; F, Female; mons, months; yrs, years; ACTH, adrenocorticotropic hormone; TSH, thyroid-stimulating hormone; T3, triiodothyronine; T4, thyroxine; GH, growth hormone; LH, luteinizing hormone; FSH, follicle-stimulation hormone.